Company Filing History:
Years Active: 2001-2011
Title: The Innovations of Kai-Uwe Schmidt
Introduction
Kai-Uwe Schmidt is a notable inventor based in Erlangen, Germany. He has made significant contributions to the field of medical technology, particularly in the area of neurological disease management. With a total of 8 patents to his name, Schmidt's work focuses on improving the quality of life for patients suffering from neurological conditions.
Latest Patents
One of Schmidt's latest patents is a method and system for allowing a neurologically diseased patient to self-monitor their actual state. This innovative approach enables patients to interactively acquire information regarding their motor functions, verbal abilities, and cognitive skills using a computer. An expert system processes this information to determine a criterion number or a statement describing the patient's state, which is then made available to the patient through an output device. Another significant patent is related to quality control in disease management services. This system enhances patient enlightenment, development, and motivation through telemonitoring of critical body values. It employs random generators to create a virtual patient from admissible data, allowing for early recognition of risk situations.
Career Highlights
Kai-Uwe Schmidt is currently associated with Siemens Aktiengesellschaft, a leading global technology company. His work at Siemens has allowed him to leverage advanced technologies to develop innovative solutions for healthcare challenges. Schmidt's contributions have been instrumental in advancing the field of telemedicine and patient self-monitoring.
Collaborations
Some of Schmidt's notable coworkers include Klaus Abraham-Fuchs and Eva Rumpel. Their collaborative efforts have further enhanced the impact of their innovations in the medical technology sector.
Conclusion
Kai-Uwe Schmidt's work exemplifies the intersection of technology and healthcare, showcasing how innovative solutions can improve patient outcomes. His patents reflect a commitment to enhancing the lives of those affected by neurological diseases.